Jove
Visualize
Contact Us

Related Concept Videos

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  3. Pulmonary Metastasis Of Giant Cell Tumor Of Bone 29 Years After Local Recurrence Resection: Implications For Long-term Surveillance.
  1. Home
  3. Pulmonary Metastasis Of Giant Cell Tumor Of Bone 29 Years After Local Recurrence Resection: Implications For Long-term Surveillance.

Related Experiment Video

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
06:53

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

2.9K

Pulmonary metastasis of giant cell tumor of bone 29 years after local recurrence resection: implications for

Qiushi Bai1, Xiao Chang1, Xiongfei Zou2

  • 1Department of Orthopedics, Peking Union Medical College Hospital, Peking Union Medical College &Chinese Academy of Medical Sciences (CAMS), No. 1 Shuaifuyuan Dongdan, Dongcheng District, Beijing, 100730, China.

Discover Oncology
|June 15, 2025

View abstract on PubMed

Summary
This summary is machine-generated.

Giant cell tumor of bone (GCTB) can metastasize to the lungs decades after treatment. This case highlights an exceptionally long 29-year interval, emphasizing the need for lifelong surveillance in GCTB patients.

Keywords:
Case reportDelayed metastasisGiant cell tumor of boneLong-term surveillancePulmonary metastasis

More Related Videos

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
07:44

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay

Published on: March 12, 2018

10.3K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.6K

Related Experiment Videos

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
06:53

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

2.9K
Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
07:44

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay

Published on: March 12, 2018

10.3K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.6K

Area of Science:

  • Orthopedic Oncology
  • Thoracic Surgery
  • Pathology

Background:

  • Pulmonary metastases from giant cell tumor of bone (GCTB) are uncommon.
  • Metastases typically manifest within years of initial diagnosis or recurrence.

Purpose of the Study:

  • To report a unique case of GCTB pulmonary metastasis occurring 29 years after the last local recurrence.
  • To emphasize the importance of long-term surveillance for patients with GCTB.

Main Methods:

  • A 52-year-old female with a history of recurrent GCTB presented with a pulmonary nodule.
  • Diagnostic workup included thoracoscopic lobectomy and histopathological examination with immunohistochemistry.

Main Results:

  • The pulmonary nodule was confirmed as a giant cell tumor metastasis.
  • This represents the longest documented interval (29 years) between GCTB recurrence and pulmonary metastasis.

    • Conclusions:

    • Extremely delayed GCTB metastases are possible, likely due to slow growth.
    • Distinguishing metastatic GCTB from primary lung cancer is challenging and can lead to overtreatment.
    • Long-term surveillance is crucial for high-risk GCTB patients.